Xeno Transplants Corporation (XENO)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Dec 30, 2025
0.00%
Market Cap 4.04K
Revenue (ttm) n/a
Net Income (ttm) -256.37K
Shares Out 40.36M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 50,000
Average Volume 25,302
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0001
Beta -38.79
RSI 38.12
Earnings Date n/a

About Xeno Transplants

Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from oth... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Country United States
Stock Exchange OTCMKTS
Ticker Symbol XENO
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.